BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 16377629)

  • 1. HER-2/neu represses the metastasis suppressor RECK via ERK and Sp transcription factors to promote cell invasion.
    Hsu MC; Chang HC; Hung WC
    J Biol Chem; 2006 Feb; 281(8):4718-25. PubMed ID: 16377629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of histone deacetylation in ras-induced down-regulation of the metastasis suppressor RECK.
    Chang HC; Liu LT; Hung WC
    Cell Signal; 2004 Jun; 16(6):675-9. PubMed ID: 15093608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downregulation of a tumor suppressor RECK by hypoxia through recruitment of HDAC1 and HIF-1alpha to reverse HRE site in the promoter.
    Lee KJ; Lee KY; Lee YM
    Biochim Biophys Acta; 2010 May; 1803(5):608-16. PubMed ID: 20080132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The tumor suppressor RECK interferes with HER-2/Neu dimerization and attenuates its oncogenic signaling.
    Hong KJ; Hsu MC; Hou MF; Hung WC
    FEBS Lett; 2011 Feb; 585(4):591-5. PubMed ID: 21255571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of histone deacetylase attenuates hypoxia-induced migration and invasion of cancer cells via the restoration of RECK expression.
    Jeon HW; Lee YM
    Mol Cancer Ther; 2010 May; 9(5):1361-70. PubMed ID: 20442303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trichostatin A, a histone deacetylase inhibitor, activates the IGFBP-3 promoter by upregulating Sp1 activity in hepatoma cells: alteration of the Sp1/Sp3/HDAC1 multiprotein complex.
    Choi HS; Lee JH; Park JG; Lee YI
    Biochem Biophys Res Commun; 2002 Aug; 296(4):1005-12. PubMed ID: 12200149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ras induces experimental lung metastasis through up-regulation of RbAp46 to suppress RECK promoter activity.
    Yeh HH; Tseng YF; Hsu YC; Lan SH; Wu SY; Raghavaraju G; Cheng DE; Lee YR; Chang TY; Chow NH; Hung WC; Liu HS
    BMC Cancer; 2015 Mar; 15():172. PubMed ID: 25885317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p16 inhibits matrix metalloproteinase-2 expression via suppression of Sp1-mediated gene transcription.
    Wang CH; Chang HC; Hung WC
    J Cell Physiol; 2006 Jul; 208(1):246-52. PubMed ID: 16575904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histone deacetylase inhibitor up-regulates RECK to inhibit MMP-2 activation and cancer cell invasion.
    Liu LT; Chang HC; Chiang LC; Hung WC
    Cancer Res; 2003 Jun; 63(12):3069-72. PubMed ID: 12810630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Silencing of transcription of the human luteinizing hormone receptor gene by histone deacetylase-mSin3A complex.
    Zhang Y; Dufau ML
    J Biol Chem; 2002 Sep; 277(36):33431-8. PubMed ID: 12091390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RECK is a target of Epstein-Barr virus latent membrane protein 1.
    Liu LT; Peng JP; Chang HC; Hung WC
    Oncogene; 2003 Nov; 22(51):8263-70. PubMed ID: 14614450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histone deacetylase inhibitors activate INK4d gene through Sp1 site in its promoter.
    Yokota T; Matsuzaki Y; Miyazawa K; Zindy F; Roussel MF; Sakai T
    Oncogene; 2004 Jul; 23(31):5340-9. PubMed ID: 15107822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of RECK in gambogic acid induced anti-invasive effect in A549 human lung carcinoma cells.
    Qi Q; Lu N; Li C; Zhao J; Liu W; You Q; Guo Q
    Mol Carcinog; 2015 Jun; 54 Suppl 1():E13-25. PubMed ID: 24532189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trichostatin A induces transforming growth factor beta type II receptor promoter activity and acetylation of Sp1 by recruitment of PCAF/p300 to a Sp1.NF-Y complex.
    Huang W; Zhao S; Ammanamanchi S; Brattain M; Venkatasubbarao K; Freeman JW
    J Biol Chem; 2005 Mar; 280(11):10047-54. PubMed ID: 15647279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcriptional control of the RECK metastasis/angiogenesis suppressor gene.
    Sasahara RM; Brochado SM; Takahashi C; Oh J; Maria-Engler SS; Granjeiro JM; Noda M; Sogayar MC
    Cancer Detect Prev; 2002; 26(6):435-43. PubMed ID: 12507228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MMP28 gene expression is regulated by Sp1 transcription factor acetylation.
    Swingler TE; Kevorkian L; Culley KL; Illman SA; Young DA; Parker AE; Lohi J; Clark IM
    Biochem J; 2010 Apr; 427(3):391-400. PubMed ID: 20144149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HER-2/neu transcriptionally activates Jab1 expression via the AKT/beta-catenin pathway in breast cancer cells.
    Hsu MC; Chang HC; Hung WC
    Endocr Relat Cancer; 2007 Sep; 14(3):655-67. PubMed ID: 17914096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin II stimulates cardiac fibroblast migration via the differential regulation of matrixins and RECK.
    Siddesha JM; Valente AJ; Sakamuri SS; Yoshida T; Gardner JD; Somanna N; Takahashi C; Noda M; Chandrasekar B
    J Mol Cell Cardiol; 2013 Dec; 65():9-18. PubMed ID: 24095877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Down-regulation of human type II collagen gene expression by transforming growth factor-beta 1 (TGF-beta 1) in articular chondrocytes involves SP3/SP1 ratio.
    Chadjichristos C; Ghayor C; Herrouin JF; Ala-Kokko L; Suske G; Pujol JP; Galéra P
    J Biol Chem; 2002 Nov; 277(46):43903-17. PubMed ID: 12186868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. v-Src-mediated down-regulation of SSeCKS metastasis suppressor gene promoter by the recruitment of HDAC1 into a USF1-Sp1-Sp3 complex.
    Bu Y; Gelman IH
    J Biol Chem; 2007 Sep; 282(37):26725-26739. PubMed ID: 17626016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.